Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis

American Journal of Cardiology

Volumn 109, Issue 3, 2012, Pages 320-326

  Mehta, Rajendra H ^a   Stebbins, Amanda S ^a   Lopes, Renato D ^a   Califf, Robert M ^a   Pieper, Karen S ^a   Armstrong, Paul W ^b   Van De Werf, Frans ^c   Hochman, Judith S ^d   White, Harvey D ^e   Topol, Eric J ^f   Alexander, John H ^a   Granger, Christopher B ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e AUCKLAND CITY HOSPITAL   (New Zealand)

^f SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BLEEDING; FEMALE; FIBRINOLYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; SURVIVAL RATE; THROMBOLYTIC THERAPY;

EID: 84855918708     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.09.012     Document Type: Article

References (22)

1. R. Malacrida, M. Genoni, A.P. Maggioni, V. Spataro, S. Parish, A. Palmer, R. Collins, T. Moccetti Third International Study of Infarct Survival Collaborative Group A comparison of the early outcome of acute myocardial infarction in women and men The Third International Study of Infarct Survival Collaborative Group N Engl J Med 338 1998 8 14 (Pubitemid 28040169)
2. H.R. Reynolds, M.E. Farkouh, A.M. Lincoff, A. Hsu, E. Swahn, Z.P. Sadowski, J.A. White, E.J. Topol, J.S. Hochman GUSTO V Investigators Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO V Arch Intern Med 167 2007 2054 2060 (Pubitemid 350041621)
3. W.D. Weaver, H.D. White, R.G. Wilcox, P.E. Aylward, D. Morris, A. Guerci, E.M. Ohman, G.I. Barbash, A. Betriu, Z. Sadowski, E.J. Topol, R.M. Califf GUSTO-I Investigators Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy GUSTO-I Investigators JAMA 275 1996 777 782 (Pubitemid 26087199)
4. H.D. White, G.I. Barbash, M. Modan, J. Simes, R. Diaz, J.R. Hampton, J. Heikkil, A. Kristinsson, S. Moulopoulos, E.A. Paolasso After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study Circulation 88 1993 2097 2103 (Pubitemid 23326087)
5. E.K. Moen, C.R. Asher, D.P. Miller, W.D. Weaver, H.D. White, R.M. Califf, E.J. Topol Long-term follow-up of gender-specific outcomes after thrombolytic therapy for acute myocardial infarction from the GUSTO-I trial Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries J Womens Health 6 1997 285 293
6. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction The GUSTO investigators N Engl J Med 329 1993 673 682
7. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators N Engl J Med 335 1996 775 782
8. A comparison of reteplase with alteplase for acute myocardial infarction The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators N Engl J Med 337 1997 1118 1123
9. F. Van De Werf, J. Adgey, D. Ardissino, P.W. Armstrong, P. Aylward, G. Barbash, A. Betriu, A.S. Binbrek, R. Califf, R. Diaz, R. Fanebust, K. Fox, C. Granger, J. Heikkil, S. Husted, P. Jansky, A. Langer, E. Lupi, A. Maseri, J. Meyer, J. Mlczoch, D. Mocceti, D. Myburgh, A. Oto, E. Paolasso, K. Pehrsson, R. Seabra-Gomes, L. Soares-Piegas, D. Sgrue, M. Tendera, E. Topol, P. Toutouzas, A. Vahanian, F. Verheugt, L. Wallentin, H. White Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial Lancet 354 1999 716 722 (Pubitemid 29405785)
10. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction Lancet 358 2001 605 613
11. HERO-2 Trial Investigators Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolysis for acute myocardial infarction The HERO-2 randomized trial Lancet 358 2002 1855 1863
12. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction The GUSTO Angiographic Investigators N Engl J Med 329 1993 1615 1622
13. R.H. Mehta, A. Stebbins, R.D. Lopes, S.V. Rao, E.R. Bates, K.S. Pieper, P.W. Armstrong, F. Van de Werf, H.D. White, R.M. Califf, J.H. Alexander, C.B. Granger Race, bleeding and outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy Am J Med 124 2011 43 57
14. K.L. Lee, L.H. Woodlief, E.J. Topol, W.D. Weaver, A. Betriu, J. Col, M. Simoons, P. Aylward, F. Van de Werf, R.M. Califf Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction Results from an international trial of 41,021 patients. GUSTO-I Investigators Circulation 91 1995 1659 1668
15. F. Van De Werf, H.V. Barron, P.W. Armstrong, C.B. Granger, S. Berioli, G. Barbash, K. Pehrsson, F.W. Verheugt, J. Meyer, A. Betriu, R.M. Califf, X. Li, N.L. Fox ASSENT-2 Investigators Assessment of the safety and efficacy of a new thrombolytic incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA Eur Heart J 22 2001 2253 2261 (Pubitemid 34000980)
16. M. Moscucci, K.A. Fox, C.P. Cannon, W. Klein, J. Lpez-Sendn, G. Montalescot, K. White, R.J. Goldberg GRACE Investigators Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823 (Pubitemid 37280247)
17. V. Vaccarino, L. Parsons, N.R. Every, H.V. Barron, H.M. Krumholz Sex-based differences in early mortality after myocardial infarction National Registry of Myocardial Infarction 2 Participants N Engl J Med 341 1999 217 225 (Pubitemid 29334519)
18. M.S. Sabatine, D.A. Morrow, R.P. Giugliano, P.B. Burton, S.A. Murphy, C.H. McCabe, C.M. Gibson, E. Braunwald Association of hemoglobin levels with clinical outcomes in acute coronary syndromes Circulation 111 2005 2042 2049 (Pubitemid 40577898)
19. N.S. Anavekar, J.J. McMurray, E.J. Velazquez, S.D. Solomon, L. Kober, J.L. Rouleau, H.D. White, R. Nordlander, A. Maggioni, K. Dickstein, S. Zelenkofske, J.D. Leimberger, R.M. Califf, M.A. Pfeffer Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 2004 1285 1295 (Pubitemid 39258422)
20. K.P. Alexander, A.Y. Chen, L.K. Newby, J.B. Schwartz, R.F. Redberg, J.S. Hochman, M.T. Roe, W.B. Gibler, E.M. Ohman, E.D. Peterson CRUSADE Investigators Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative Circulation 114 2006 1380 1387 (Pubitemid 44462663)
21. H.J. Gorton, E.R. Warren, N.A. Simpson, G.R. Lyons, M.O. Columb Thromboelastography identifies sex-related differences in coagulation Anesth Analg 91 2000 1279 1281
22. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study The Writing Group for the Estradiol Clotting Factors Study Thromb Haemost 75 1996 476 480